(Fort Worth, TX) --- Michael Steadman, President of Tissue Management for HEALTHPOINT®, Ltd., a DFB Pharmaceuticals Inc. affiliate company, has announced that Diane Cooper, Ph.D. has joined the HEALTHPOINT team as Director of Clinical Affairs for Tissue Management.

         A recognized leader in clinical research, nursing, education, and industry, Dr. Cooper’s focus on wound healing has spanned four decades and included, among other prestigious roles, faculty appointments in Schools of Nursing at Michigan State University, University of California San Francisco, and the University of Texas Medical Branch in Galveston; and service as the Worldwide Medical Director for Johnson & Johnson Wound Management, Ethicon in New Jersey.

         “We are very honored to add Dr. Cooper to our clinical department, greatly enriching an already exemplary Tissue Management team. Her knowledge and dedication mirror and bolster HEALTHPOINT’s commitment to serving wound care patients,” said Mr. Steadman. “Dr. Cooper will play a key role in evolving our business and its clinical leadership, resulting in tremendous impact on the future of this population across the country.”

         Diane Cooper began her career in wound care as a nurse for chronically ill patients. Early on, she realized that in most health care settings, treatment of wounds was often lacking, inconsistent, even contraindicated. She sought solutions through extensive education, clinical work, teaching, specialized research, and leadership for the pharmaceutical industry. Her expansive academic and clinical careers now culminate in her new position at HEALTHPOINT.

         “HEALTHPOINT’s evidence-based products are helping patients now, and I am delighted to be engaged in processes to further increase innovation and consistency of care,” said Dr. Cooper. “From the beginning, I wanted patients to heal as quickly as possible, but in order to combat their wounds, I needed an arsenal of knowledge that, at that time, was not readily accessible. Now, by advancing accessible clinical research and education at HEALTHPOINT, we can actively influence the future of wound healing science and find practical solutions to wound healing problems.”

         Dr. Cooper began her education at Seattle University, graduating with a bachelor of science in nursing. She then went on to Holy Names College earning a bachelor of arts in biology. Returning to Seattle, she received her master of nursing in physiological nursing at the University of Washington. Pursuing her passion in wound healing, Dr. Cooper attended the University of Pennsylvania where she obtained her doctor of philosophy in nursing with an emphasis in wound healing and completed a Robert Wood Johnson Post Doctoral Fellowship in Wound Healing at the University of California at San Francisco.

         Since its inception in 1992, HEALTHPOINT has established a U.S. presence in the research, development, and marketing of branded pharmaceuticals, over the counter drugs, and medical devices for tissue management, dermatology, and surgical indications. An aggressive research and development effort has brought HEALTHPOINT’s unique technologies to the market, setting the pace for its highly trained field sales organization of direct sales representatives. HEALTHPOINT, with over 300 employees, is a DFB Pharmaceuticals, Inc. affiliate company. HEALTHPOINT is based in Fort Worth, Texas. Visit HEALTHPOINT’s web site at www.healthpoint.com.

###